B

Brainsway Ltd
TASE:BWAY

Watchlist Manager
Brainsway Ltd
TASE:BWAY
Watchlist
Price: 2 220 ILS 6.42%
Market Cap: 729.4m ILS
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one BWAY stock under the Base Case scenario is 611.4 ILS. Compared to the current market price of 2 220 ILS, Brainsway Ltd is Overvalued by 72%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BWAY Relative Value
Base Case
611.4 ILS
Overvaluation 72%
Relative Value
Price
B
Worst Case
Base Case
Best Case

Valuation Multiples

5
P/S
P/S
Price to Sales
5
vs History
20
vs Industry
30
Median 3Y
2.8
Median 5Y
3.9
Industry
2.4
Forward
1.2
More Details
55.1
P/E
P/E
Price to Earnings
55.1
vs History
12
vs Industry
4
Median 3Y
-2.6
Median 5Y
-9.1
Industry
22.5
Forward
29.2
More Details
17.8
P/OCF
P/OCF
Price to OCF
17.8
vs History
14
vs Industry
22
Median 3Y
11.2
Median 5Y
-3.5
Industry
14.4
More Details
29.8
P/FCFE
P/FCFE
Price to FCFE
29.8
vs History
4
vs Industry
13
Median 3Y
-2.9
Median 5Y
-10.5
Industry
20.4
More Details
3.4
P/B
P/B
Price to Book Value
3.4
vs History
17
vs Industry
23
Median 3Y
2.3
Median 5Y
2.3
Industry
2.2
More Details
3.4
EV/S
EV/S
Enterprise Value to Sales
3.4
vs History
22
vs Industry
37
Median 3Y
1.2
Median 5Y
2.3
Industry
2.6
Forward
0.8
More Details
4.6
EV/GP
EV/GP
Enterprise Value to Gross Profit
4.6
vs History
20
vs Industry
51
Median 3Y
1.6
Median 5Y
2.9
Industry
5.2
More Details
40
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
40
vs History
12
vs Industry
6
Median 3Y
1.4
Median 5Y
-0.9
Industry
11.9
Forward
23.9
More Details
79.3
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
79.3
vs History
9
vs Industry
3
Median 3Y
1
Median 5Y
-4.9
Industry
16.3
Forward
18
More Details
12.3
EV/OCF
EV/OCF
Enterprise Value to OCF
12.3
vs History
17
vs Industry
32
Median 3Y
5.3
Median 5Y
1.4
Industry
14.5
More Details
18.6
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
18.6
vs History
3
vs Industry
24
Median 3Y
1.7
Median 5Y
-4.1
Industry
17.9
More Details
7.1
EV/IC
EV/IC
Enterprise Value to IC
7.1
vs History
11
vs Industry
11
Median 3Y
3.3
Median 5Y
5.4
Industry
1.9
More Details

Multiples Across Competitors

BWAY Competitors Multiples
Brainsway Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
IL
Brainsway Ltd
TASE:BWAY
729.4m ILS 5 55.1 40 79.3
US
Abbott Laboratories
NYSE:ABT
225.1B USD 5.2 16.1 21.3 30
US
Intuitive Surgical Inc
NASDAQ:ISRG
172.9B USD 18.9 66.3 51.6 62
US
Boston Scientific Corp
NYSE:BSX
151.7B USD 8.2 60.6 34 47
US
Stryker Corp
NYSE:SYK
144.8B USD 6.1 49.6 24.6 29.7
IE
Medtronic PLC
NYSE:MDT
119.1B USD 3.6 25.5 14.4 20.7
CN
Hongchang International Co Ltd
OTC:HCIL
71.1B USD 25 199.4 -319 603.8 -636 512.4 -397 198
DE
Siemens Healthineers AG
XETRA:SHL
52B EUR 2.2 23.9 13.5 18.9
US
Becton Dickinson and Co
NYSE:BDX
56.2B USD 2.7 37 14.4 26.8
US
IDEXX Laboratories Inc
NASDAQ:IDXX
53.2B USD 13.2 54 38.8 43.1
US
Edwards Lifesciences Corp
NYSE:EW
45.5B USD 8 11 24.2 26.6
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
IL
B
Brainsway Ltd
TASE:BWAY
Average EV/EBITDA: 27.7
40
N/A N/A
US
Abbott Laboratories
NYSE:ABT
21.3
13%
1.6
US
Intuitive Surgical Inc
NASDAQ:ISRG
51.6
25%
2.1
US
Boston Scientific Corp
NYSE:BSX
34
22%
1.5
US
Stryker Corp
NYSE:SYK
24.6
12%
2
IE
Medtronic PLC
NYSE:MDT
14.4
7%
2.1
CN
H
Hongchang International Co Ltd
OTC:HCIL
Negative Multiple: -636 512.4 N/A N/A
DE
Siemens Healthineers AG
XETRA:SHL
13.5
14%
1
US
Becton Dickinson and Co
NYSE:BDX
14.4
11%
1.3
US
IDEXX Laboratories Inc
NASDAQ:IDXX
38.8
12%
3.2
US
Edwards Lifesciences Corp
NYSE:EW
24.2
12%
2

See Also

Summary
BWAY intrinsic value, competitors valuation, and company profile.
DCF Valuation
BWAY stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BWAY stock valuation using valuation multiples.
Wall Street Estimates
BWAY price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BWAY stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 275,000+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.